Crystal structures have also been completed with nonsteroidal antagonist ligands bound to the AR pocket, advancing our understanding of how drug-like molecules can be designed and improved (80, 81).
Crystal structures have also been completed with nonsteroidal antagonist ligandsbound to the AR pocket, advancing our understanding of how drug-like molecules can bedesigned and improved (80, 81).